Cargando…
Quantitative analysis of plasma DNA in anal cancer patients
INTRODUCTION: The availability and non-invasiveness of circulating cell-free DNA (cfDNA) opens up new possibilities for real-time serial testing. The relationship between cfDNA concentration, clinical factors and suitability for monitoring was analyzed in patients with newly diagnosed anal squamous...
Autores principales: | Małusecka, Ewa, Giglok, Monika, Suwiński, Rafał, Rutkowski, Tomasz Wojciech, Mazurek, Agnieszka Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319180/ https://www.ncbi.nlm.nih.gov/pubmed/35903208 http://dx.doi.org/10.5114/wo.2022.118132 |
Ejemplares similares
-
Circulating HPV16 DNA in Blood Plasma as Prognosticator and Early Indicator of Cancer Recurrence in Radio-Chemotherapy for Anal Cancer
por: Mazurek, Agnieszka M., et al.
Publicado: (2023) -
Significance of HPV16 Viral Load Testing in Anal Cancer
por: Małusecka, Ewa, et al.
Publicado: (2020) -
Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet
por: Kozłowska, Emilia, et al.
Publicado: (2020) -
Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy
por: Butkiewicz, Dorota, et al.
Publicado: (2021) -
Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients
por: Zajkowicz, A, et al.
Publicado: (2015)